References
- Pliška V. Pharmacological approaches to the identification and classification of myometrial oxytocin receptors. J. Receptor Res. 1988; 8: 245–259
- Pliška V., Heiniger J. Structural requirements of the oxytocin receptor in rat uterus. Free-Wilson analysis in a series of competitive oxytocin inhibitors. Int. J. Peptide Protein Res. 1988; 31: 520–536
- Free S. M., Wilson J. W. A mathematical contribution to structure-activity studies. J. Med. Chem. 1964; 7: 395–399
- Pliška V. Affinity of 1,2-substituted oxytocin analogues to the uterus receptor: Free-Wilson and Hansch analysis. Experientia 1978; 34: 1190–1192
- Pliška V., Charton M. Quantitative structure-activity relationships (QSAR) of neurohypophyseal hormone analogs acting as oxytocin inhibitors on uterus in vitro. Peptides-Chemistry, Structure and Biology, J. E. Rivier, G. R. Marshall. ESCOM Science Publ. B.V., Leiden 1990; 290–292
- Pliška V. Dose-response models: similarity with population growth dynamics. Trends Pharmacol. Sci. (TIPS) 1987; 2: 50–52
- Pliška V., Marbach P. Some biological properties of an “irreversible” antagonist of neurohypophyseal hormones, deamino-[Phe(4–BrCH2 CONH)2]-oxytocin, and its isosteric analogue, deamino-[Phe(4–CH3CH2CONH)2]-oxytocin. Eur. J. Pharmacol. 1978; 49: 213–222
- Charton M. Electrical effect substituent constants for correlation analysis. Progr. Phys. Org. Chem. 1981; 13: 119–252
- Charton M. The quantitative description of amino acid, peptide, and protein properties and bioactivities. Progr. Phys. Org. Chem. 1990; 18, in press
- Charton M., Charton B. I. The structural dependence of amino acid hydrophobicity parameters. J. theor. Biol. 1982; 99: 629–644
- Pliška V., Heiniger J. Free-Wilson analysis of biologically active peptides: oxytocin analogues acting as uterotonic antagonists. QSAR in Drug Design and Toxicology, D. Hadzi, B. Jerman-Blazic. Elsevier Scientific Publ., Amsterdam 1987; 263–267
- Pliška V., Heiniger J., Müller-Lhotsky A., Pliska P., Ekberg B. Binding of oxytocin to uterine cells in vitro. Occurence of several binding site populations and reidentification of oxytocin receptors. J. Biol. Chem. 1986; 261: 16984–16989
- Birdsall N. J. M., Burgen A. S.V., Hulme E. C. The binding of agonists to brain muscarinic receptors. Mol. Pharmacol. 1978; 14: 723–736
- Ruzycky A. L., Crankshaw D. J. Role of inositol phospholipid hydrolysis in the initiation of agonist-induced contractions of rat uterus: effect of domination by 17B–estradiol and progesterone. Can. J. Physiol. Pharmacol. 1988; 66: 10–17
- Pfeiffer C. C. Optical isomerism and pharmacological action, a generalization. Science 1956; 124: 29–31
- Fujita T., Iwasa J., Hansch C. A new substituent constant, derived from partition coefficients. J. Am. Chem. Soc. 1964; 86: 5175–5180
- Fauchère J.-L., Charton M., Kier L. B., Verloop A., Pliska V. Amino acid side chain parameters for correlation studies in biology and pharmacology. Int. J. Peptide Protein Res. 1988; 32: 269–278